Caso clínico
Enteropatía perdedora de proteínas asociada a lupus eritematoso sistémico refractaria con buena respuesta a rituximab
Protein-losing enteropathy associated with refractory systemic lupus erythematosus with a good response to rituximab
Leído
23819
Vecesse ha leído el artículo
5957
Total PDF
17862
Total HTML
| año/Mes | Html | Total | |
|---|---|---|---|
| 2025 11 | 83 | 8 | 91 |
| 2025 10 | 21 | 93 | 114 |
| 2025 9 | 0 | 58 | 58 |
| 2025 8 | 0 | 93 | 93 |
| 2025 7 | 0 | 51 | 51 |
| 2025 6 | 7 | 53 | 60 |
| 2025 5 | 285 | 74 | 359 |
| 2025 4 | 293 | 53 | 346 |
| 2025 3 | 283 | 55 | 338 |
| 2025 2 | 285 | 48 | 333 |
| 2025 1 | 214 | 80 | 294 |
| 2024 12 | 191 | 52 | 243 |
| 2024 11 | 215 | 78 | 293 |
| 2024 10 | 177 | 70 | 247 |
| 2024 9 | 168 | 45 | 213 |
| 2024 8 | 206 | 68 | 274 |
| 2024 7 | 154 | 49 | 203 |
| 2024 6 | 186 | 60 | 246 |
| 2024 5 | 257 | 43 | 300 |
| 2024 4 | 165 | 43 | 208 |
| 2024 3 | 184 | 62 | 246 |
| 2024 2 | 119 | 27 | 146 |
| 2024 1 | 149 | 40 | 189 |
| 2023 12 | 140 | 46 | 186 |
| 2023 11 | 146 | 39 | 185 |
| 2023 10 | 185 | 60 | 245 |
| 2023 9 | 217 | 60 | 277 |
| 2023 8 | 197 | 47 | 244 |
| 2023 7 | 176 | 51 | 227 |
| 2023 6 | 163 | 50 | 213 |
| 2023 5 | 206 | 75 | 281 |
| 2023 4 | 110 | 26 | 136 |
| 2023 3 | 216 | 57 | 273 |
| 2023 2 | 109 | 50 | 159 |
| 2022 1 | 144 | 52 | 196 |
| 2022 12 | 153 | 60 | 213 |
| 2022 11 | 196 | 55 | 251 |
| 2022 10 | 243 | 49 | 292 |
| 2022 9 | 244 | 54 | 298 |
| 2022 8 | 182 | 94 | 276 |
| 2022 7 | 138 | 77 | 215 |
| 2022 6 | 190 | 91 | 281 |
| 2022 5 | 178 | 97 | 275 |
| 2022 4 | 186 | 72 | 258 |
| 2022 3 | 178 | 101 | 279 |
| 2022 2 | 146 | 50 | 196 |
| 2021 1 | 148 | 63 | 211 |
| 2021 12 | 157 | 69 | 226 |
| 2021 11 | 191 | 84 | 275 |
| 2021 10 | 146 | 65 | 211 |
| 2021 9 | 163 | 105 | 268 |
| 2021 8 | 111 | 65 | 176 |
| 2021 7 | 128 | 67 | 195 |
| 2021 6 | 135 | 78 | 213 |
| 2021 5 | 169 | 81 | 250 |
| 2021 4 | 355 | 148 | 503 |
| 2021 3 | 228 | 55 | 283 |
| 2021 2 | 185 | 64 | 249 |
| 2020 1 | 134 | 64 | 198 |
| 2020 12 | 153 | 57 | 210 |
| 2020 11 | 194 | 81 | 275 |
| 2020 10 | 186 | 69 | 255 |
| 2020 9 | 177 | 75 | 252 |
| 2020 8 | 165 | 81 | 246 |
| 2020 7 | 202 | 61 | 263 |
| 2020 6 | 117 | 47 | 164 |
| 2020 5 | 155 | 55 | 210 |
| 2020 4 | 139 | 34 | 173 |
| 2020 3 | 150 | 42 | 192 |
| 2020 2 | 180 | 51 | 231 |
| 2020 1 | 208 | 59 | 267 |
| 2019 12 | 159 | 45 | 204 |
| 2019 11 | 194 | 62 | 256 |
| 2019 10 | 227 | 49 | 276 |
| 2019 9 | 210 | 60 | 270 |
| 2019 8 | 233 | 62 | 295 |
| 2019 7 | 217 | 70 | 287 |
| 2019 6 | 175 | 52 | 227 |
| 2019 5 | 315 | 125 | 440 |
| 2019 4 | 240 | 84 | 324 |
| 2019 3 | 238 | 52 | 290 |
| 2019 2 | 162 | 50 | 212 |
| 2019 1 | 135 | 53 | 188 |
| 2018 12 | 186 | 73 | 259 |
| 2018 11 | 139 | 13 | 152 |
| 2018 10 | 110 | 17 | 127 |
| 2018 9 | 86 | 16 | 102 |
| 2018 8 | 86 | 12 | 98 |
| 2018 7 | 54 | 12 | 66 |
| 2018 5 | 11 | 1 | 12 |
| 2018 4 | 86 | 11 | 97 |
| 2018 3 | 115 | 8 | 123 |
| 2018 2 | 97 | 4 | 101 |
| 2018 1 | 91 | 9 | 100 |
| 2017 12 | 68 | 11 | 79 |
| 2017 11 | 122 | 13 | 135 |
| 2017 10 | 110 | 7 | 117 |
| 2017 9 | 100 | 12 | 112 |
| 2017 8 | 69 | 12 | 81 |
| 2017 7 | 95 | 18 | 113 |
| 2017 6 | 102 | 17 | 119 |
| 2017 5 | 140 | 23 | 163 |
| 2017 4 | 108 | 21 | 129 |
| 2017 3 | 91 | 19 | 110 |
| 2017 2 | 247 | 14 | 261 |
| 2016 1 | 99 | 20 | 119 |
| 2016 12 | 114 | 19 | 133 |
| 2016 11 | 165 | 22 | 187 |
| 2016 10 | 181 | 33 | 214 |
| 2016 9 | 253 | 38 | 291 |
| 2016 8 | 178 | 21 | 199 |
| 2016 7 | 71 | 23 | 94 |
| 2016 5 | 1 | 0 | 1 |
| 2016 4 | 6 | 0 | 6 |
| 2016 3 | 8 | 0 | 8 |
| 2016 2 | 4 | 116 | 120 |
| 2015 1 | 3 | 122 | 125 |
Mostrar todo
